The hearing implant maker forecasts low single-digit sales growth and underlying net profit between $330 million and $350 million for FY27.
Cochlear reported full-year revenue of $2.34 billion, aligning with market expectations. The company anticipates low single-digit constant currency sales growth in FY27, driven by gradual improvements in developed market cochlear implant performance and cost discipline.
For FY27, Cochlear guided underlying net profit between $330 million and $350 million. The outlook assumes targeted investment in growth initiatives while maintaining operational efficiency.
No immediate market reaction was disclosed in the release.